About Franco-Indian Pharmaceuticals
Franco-Indian Pharmaceuticals is a Healthcare company based in Mumbai (India). Pharmaceutical manufacturing, formulation development, and global distribution of medications in India. The company has 1,524 employees. Its Indian entity Franco-Indian Pharmaceuticals Private Limited reported revenue of ₹989 Cr. Franco-Indian Pharmaceuticals offers products and services including Oral Penicillin V and Metformin. Its focus areas include Research and Development, Drug Development, Innovation Alliances and Pharmaceuticals.
Company details
Franco-Indian Pharmaceuticals Pvt. Ltd. was established in 1949 and is noted for its contributions to accessible healthcare through the introduction of key medications like oral Penicillin V and Cortisone. A workforce of nearly 2000 employees is maintained, with operations spanning manufacturing and research facilities in Mumbai. Exports to Asia, Africa, and other regions are handled via distribution networks, while a portfolio exceeding 400 crore in turnover includes brands for diabetes and respiratory care. Integrity and excellence are upheld in its practices, ensuring quality and affordability in pharmaceutical offerings.
- Headquarters Mumbai, India
- Employees 1,524
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website francoindian.com
- Legal Name Franco-Indian Pharmaceuticals Pvt. Ltd.
- Date of Incorporation 01 May, 1959
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹989 Cr
FY 2024 · 0% YoY
- Net Profit₹150 Cr
FY 2024 · 15% margin
- EBITDA₹228 Cr
FY 2024 · 23% margin
- Employee Count1,524
Associated legal entities of Franco-Indian Pharmaceuticals
Franco-Indian Pharmaceuticals operates through Franco-Indian Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Franco-Indian Pharmaceuticals Private Limited CIN U24239MH1959PTC011347 | Active | 01 May 1959 | Mumbai, Maharashtra | ₹989 Cr | 1,524 | 7 | View details |
Products & Services of Franco-Indian Pharmaceuticals
Franco-Indian Pharmaceuticals offers a comprehensive portfolio of products and services, including Oral Penicillin V and Metformin.
This product was introduced as the first oral Penicillin in India and is utilized for treating bacterial infections.
Metformin is provided as an economical treatment option for Diabetes and is part of a well-known range in the market.
Board of directors of Franco-Indian Pharmaceuticals Private Limited (Franco-Indian Pharmaceuticals)
Franco-Indian Pharmaceuticals Private Limited is the primary company behind Franco-Indian Pharmaceuticals. The board of Franco-Indian Pharmaceuticals Private Limited currently have 7 directors; the longest-serving is Pascal Postel, appointed in 1998. 16 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pascal Postel DIN 00026853 | Managing Director | 01 Jan 1998 | 28 yrs 10 mo | Franco-Indian Pharmaceuticals Private Limited |
| Lalsa Balgovind Yadav DIN 00055974 | Director | 05 Aug 2005 | 21 yrs 3 mo | Franco-Indian Pharmaceuticals Private Limited |
| Jagdish Purushottamdas Mehta DIN 00053296 | Director | 19 Mar 2014 | 12 yrs 7 mo | Franco-Indian Pharmaceuticals Private Limited |
| Santosh Mohan Chavan DIN 09097972 | Director | 09 Mar 2021 | 5 yrs 7 mo | Franco-Indian Pharmaceuticals Private Limited |
| Alexandre Johan Postel DIN 03588038 | Director | 13 Dec 2022 | 3 yrs 10 mo | Franco-Indian Pharmaceuticals Private Limited |
| Errol James Desouza DIN 00053201 | Director | 01 Mar 2023 | 3 yrs 8 mo | Franco-Indian Pharmaceuticals Private Limited |
| Ajit Anant Mangalvede DIN 10140076 | Director | 02 May 2023 | 3 yrs 6 mo | Franco-Indian Pharmaceuticals Private Limited |
Financials of Franco-Indian Pharmaceuticals
Figures of Franco-Indian Pharmaceuticals Private Limited, the primary company behind Franco-Indian Pharmaceuticals, for FY 2024. Revenue was ₹989 Cr (0% year on year). Net profit was ₹150 Cr (15% margin). EBITDA was ₹228 Cr (23% margin). Revenue has grown at a compounded annual rate of 0% over three years and +3% over five years.
- ₹989 CrRevenue · FY 2024 · 0% YoY
- ₹150 CrNet profit · 15% margin
- ₹228 CrEBITDA · 23% margin
- ₹46.3 LakhPaid-up capital
- 1,524Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Franco-Indian Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Franco-Indian Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Franco-Indian Pharmaceuticals
The website of Franco-Indian Pharmaceuticals (francoindian.com) receives about 2.9K visits a month and ranks #1,977,293 among all websites worldwide, #2,687 in Biotechnology and Pharmaceuticals.
- Monthly visits2.9K
▼ 77.2% vs previous month
- Unique visitors7.1K
per month
- Global rank#1,977,293
among all websites
- Category rank#2,687
Health · Biotechnology and Pharmaceuticals
- Bounce rate77%
- Pages per visit1.5
- Average visit17 sec
- DevicesDesktop 17% · Mobile 83%
Websites whose visitors overlap most with Franco-Indian Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| centurypharma.com | 100% | 2.1K | #6,652,065 | View details | |
| cooperpharma.com | 92% | 17.9K | #1,398,892 | View details | |
| pharmacosmos.com | 78% | #2,987,105 | View details | ||
ferrlecit.com | ferrlecit.com | 50% | – | ||
ferralet.com | ferralet.com | 49% | #9,714,421 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Franco-Indian Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Franco-Indian Pharmaceuticals
Franco-Indian Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Franco-Indian Pharmaceuticals has 1,524 employees.
The primary company behind Franco-Indian Pharmaceuticals, Franco-Indian Pharmaceuticals Private Limited, reported revenue of ₹989 Cr for FY 2024, down 0% year on year.
Franco-Indian Pharmaceuticals Pvt. Ltd. was established in 1949 and is noted for its contributions to accessible healthcare through the introduction of key medications like oral Penicillin V and Cortisone. A workforce of nearly 2000 employees is maintained, with operations spanning manufacturing and research facilities in Mumbai. Exports to Asia, Africa, and other regions are handled via distribution networks, while a portfolio exceeding 400 crore in turnover includes brands for diabetes and respiratory care. Integrity and excellence are upheld in its practices, ensuring quality and affordability in pharmaceutical offerings.
Franco-Indian Pharmaceuticals offers Oral Penicillin V and Metformin.
Franco-Indian Pharmaceuticals operates through Franco-Indian Pharmaceuticals Private Limited.
The legal entities of Franco-Indian Pharmaceuticals currently have 7 directors, including Santosh Mohan Chavan, Jagdish Purushottamdas Mehta, Pascal Postel and others.